Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.
Alain
A
Meyer
Arnaud
A
Theulin
Emmanuel
E
Chatelus
Xavier
X
Argemi
Christelle
C
Sordet
Rose Marie
RM
Javier
Yves
Y
Hansmann
Jean
J
Sibilia
Jacques-Eric
JE
Gottenberg
D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D002169:Campylobacter Infections / Q000175:diagnosis / Q000276:immunology*; D002168:Campylobacter fetus / Q000276:immunology / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000276:immunology*; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab